Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

What To Do If A Dog Is Having A Seizure -- Recommendations by MedVet Chicago's Veterinary Neurologist about Canine Epilepsy
  • USA - English


News provided by

MedVet Medical & Cancer Centers for Pets

Feb 08, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Dr. Michael Podell of MedVet Chicago states, “There is no cure for epilepsy. Living with epilepsy can be extremely difficult not only for the humans and dogs that have the disease but also for the caregivers.”

Post this

Chicago, IL (PRWEB) February 08, 2016 -- Epilepsy is a seizure disorder that occurs in humans and dogs. MedVet Medical & Cancer Centers for Pets is participating in promoting International Epilepsy Day on Monday, February 8th. This is an annual event to promote awareness of epilepsy worldwide. Epileptic seizures can vary from brief and very subtle trembling to long periods of vigorous shaking and disrupt lifestyles for affected people and their canine best friends. Similar to people with epilepsy, the cause is unknown in most dogs, although more serious problems, such as trauma, infections or cancers also occur.

According to the American Epilepsy Society, 1 in 26 Americans will develop epilepsy in their lifetime adding more than 200,000 new epilepsy cases annually to the 3 million already living with the condition in the US. According to Dr. Michael Podell, MSc, DVM, Diplomate ACVIM (Neurology), head of the Neurology and Neurosurgery department at MedVet Chicago and Affiliate Professor in the Department of Neurosurgery, Pritzker School of Medicine at the University of Chicago, “the prevalence of epilepsy in dogs in the U.S. may range from 0.55 percent to 5 percent.” That could mean that about two million dogs are affected.

Dr. Michael Podell of MedVet Chicago states, “There is no cure for epilepsy. Living with epilepsy can be extremely difficult not only for the humans and dogs that have the disease but also for the caregivers. Unlike other diseases, a long period of normal activity may occur between the seizure events. The focus of treatment is to balance the best quality of life for the patient and owner with optimal seizure control.” The diagnosis of epilepsy involves consultation with a board-certified veterinary neurologist who may recommend more advanced diagnostic tests such as magnetic resonance imaging (MRI). Many patients do not necessarily need more tests, but to start appropriate anticonvulsant treatment. Many of these drugs used to control seizures in humans and dogs are the same.

Dr. Podell was the chair of the panel and lead author on the upcoming American College of Veterinary Internal Medicine (ACVIM) Consensus Statement by the College of Neurology to be published in the Journal of Veterinary Internal Medicine titled: “2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs.” Dr. Podell states that he hopes this information “helps to improve the care and treatment of epileptic dogs throughout the world.” Similar to the International League Against Epilepsy, which works to provide guidelines for best practice standards of care for epileptic people, the International Veterinary Epilepsy Task Force (IVETF) was recently established to work towards these same goals in veterinary medicine. Dr. Podell is one of the founding members of the IVETF, which held their inaugural meeting this past year, and has also published several consensus statements on epilepsy.

About Canine Epilepsy
Epilepsy is a common disease in dogs and can occur in most other animal species. The disorder is characterized by unpredictable seizures in which the brain produces sudden bursts of electrical energy. Seizures differ in movements and alternations in consciousness from subtle to severe tonic-clonic muscle movements. There is not a cure for epilepsy however daily medication can decrease the frequency and severity of the seizures in the majority of dogs. Commonly used drugs include phenobarbital, bromide, zonisamide, and levetiracetam.

What to Do if A Dog is Having a Seizure
If your dog has a seizure, keep your dog safe. If your dog is near stairs or water, move them away while taking care not to get bit. Seizuring dogs are not aware of what they are doing and their chomping behavior can result in severe bites. Dogs will not swallow their tongues so stay away from their mouths. Most seizures cease in two to three minutes. If your dog seizures, please call your veterinarian or emergency clinic immediately.

If a pet is experiencing a medical emergency, pet owners are encouraged to immediately contact their family veterinarian or MedVet Chicago for guidance and help. MedVet Chicago can be reached 24 hours a day, every day of the year, by calling (773) 281-7110 or in-person at 3123 N. Clybourn Ave., Chicago, IL 60618. For more about MedVet, go to medvetforpets.com.

About MedVet Chicago
MedVet Chicago (formerly Chicago Veterinary Emergency & Specialty Center) is a 24-hour emergency, critical care and specialty animal hospital which is part of the MedVet Medical & Cancer Centers for Pets patient care family. MedVet is employee owned, veterinary led, and is leading specialty healthcare for pets. MedVet provides specialty referral services for in-depth care and patient management, as well as emergency services, available 24 hours a day, 365 days a year. More than 100,000 dogs and cats are treated annually at MedVet’s expanding network of medical centers across the country.

About Dr. Podell
Michael Podell, DVM, MSc, Diplomate ACVIM (Neurology) is a board-certified veterinary neurologist at MedVet Chicago. Dr. Podell was a Full Professor in the Departments of Veterinary Clinical Sciences and Neurology at The Ohio State University until 2002, when he moved to Chicago to open the area’s first veterinary neurology and neurosurgery practice. Currently, Dr. Podell continues to demonstrate his passion for veterinary medicine and neurological sciences through his daily work with neurologic patients at MedVet Chicago, numerous published book chapters and articles, and as an Affiliate Professor in the Department of Neurosurgery, Pritzker School of Medicine at the University of Chicago. Dr. Podell is actively engaged in comparative medicine curative research for animals and people through clinical trials, and educating the future generation of veterinary neurologists.

Contact: Eva Kaltenbach
MedVet Medical & Cancer Centers for Pets
(773) 281-7110 x1101
eva.kaltenbach(at)medvetforpets(dot)com

Tami Adcock, MedVet Medical & Cancer Centers for Pets, http://www.medvetforpets.com, +1 6144314400, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.